Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3347752 | Diagnostic Microbiology and Infectious Disease | 2008 | 5 Pages |
Abstract
The antimicrobial susceptibility profile of 419 clinical isolates of Pseudomonas aeruginosa obtained from intensive care unit patients was determined. Amikacin and piperacillin/tazobactam were the most active antimicrobials evaluated. Fifty isolates (11.9%) were resistant to antimicrobials from ≥3 classes. Ninety-six percent of multidrug-resistant (MDR) isolates remained fully susceptible to colistin (polymyxin E).
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Andrew Walkty, Melanie DeCorby, Kim Nichol, Michael R. Mulvey, Daryl Hoban, George Zhanel,